In a study published in this rournal in 1992 Alvarez et al described normal profiles of plasma melatonin in a group of 12 patients with the delayed sleep phase syndrome, an idiopathic sleep disorder manifested by an inability to fall asleep and wake spontaneously at desired clock times and a phase delay of the major sleep episode in relation to the desired time for sleep.' Because of animal data indicating a central role of melatonin in circadian regulation, they obtained 24 hour plasma melatonin profiles of patients with delayed sleep phase syndrome in a fixed light-dark ward environment (dark period 2300-0800). On average, plasma melatonin concentrations peaked about 0400 and reflected a normal adult pattern of melatonin secretion. Intrinsic patterns of human melatonin secretion, however, may be masked by patterns of sleep and light exposure.2 Evaluation of circadian oscillator rhythms are best unmasked in "constant routine" periods of at least 24 hours of virtual darkness that are designed to minimise or distribute evenly the possible "masking effects" of sleep, posture, exercise, meals, and light, which might distort the intrinsic patterns of circadian rhythms.' Therefore, we evaluated circadian plasma melatonin concentrations and core body temperature with a 24 hour dark (<1 lux) period constant routine in a patient with the delayed sleep phase syndrome A 43 year old woman presented to our clinic with a 30 year history of the delayed sleep phase syndrome, primarily manifest by an inability to fall asleep before 0400 and a difficulty in waking before 1200 daily. Although brain MRI when she was 36 had shown a pineal cyst, no other relevant abnormalities were discovered on routine physical examination or laboratory testing. Medical history was remarkable only for her having undergone a complete hysterectomy at the age of 41 after complications from uterine fibroidectomy. There was no history of affective or psychotic disorders.
Over a six week period in our inpatient unit the patient was tapered off benzodiazepines over four weeks and then remained medication free for another two weeks. She showed occasional irritability that was attributed to benzodiazepine withdrawal. During this period the patient was allowed to regulate her circadian exposure to light and dark and to sleep when she wished. Although her sleep was irregular from night to night, she would go to sleep between 0400 and 0830 each morning and sleep until 1000 to 1300.
At the conclusion of this interval, a 24 hour constant routine procedure was undertaken whereby the patient was awake, in virtual darkness (<1 lux), and ate small isocaloric meals every two hours. She was kept awake by engaging her in conversation and sedentary games. Blood samples were obtained via an indwelling intravenous catheter every 30 minutes (1700-1700). Plasma melatonin was measured by StockGrand Ltd (Department of Biochemistry, University of Surrey, UK) with a radioimmunoassay. Rectal temperature was monitored continuously throughout the procedure.
The patient's plasma melatonin rhythm (figure), peaking at 0830, was remarkable particularly for its delayed phase position compared with that typically seen in normal subjects, which peaks in the middle of the night. Rectal temperature exhibited a similarly delayed profile with the nocturnal temperature minimum occurring between about 0500 and 1230.
The delayed timing of the plasma melatonin peak and the rectal temperature minimum provide preliminary evidence that a biological abnormality may be present in the delayed sleep phase syndrome and that the biological dysregulation matches the clinical features of the syndrome. Although it is theoretically possible that our plasma melatonin results differed from those of Alvarez et all because their sample consisted mostly of men and our patient was a woman, we have no reason to think that the sex difference might have accounted for the different melatonin profiles. Rather, we suspect that we were able to identify a phase shift in the melatonin profile because its underlying rhythm was unmasked by the 24 hour dim light conditions. Our finding of a similar delay in the circadian temperature rhythm confirms a previous report by Guilleminault et al.4 It is noteworthy that phase advancement of the circadian rhythm of body temperature has been associated with successful treatment of the delayed sleep phase syndrome.5
If this report of delayed plasma melatonin and body temperature rhythms in the delayed sleep phase syndrome is replicated in a large sample of patients, it will provide further evidence that plasma melatonin and body temperature rhythms can serve as reliable markers of phase setting of the human body clock that regulates sleep. The establishment of a biological abnormality in this disorder might also provide some solace to those with the disorder, who until now, might have been told that their sleep-wake disorder was psychological in origin. It will also provide biological markers for the diagnosis and progress of treatment of the syndrome. DAN 
